Pfizer to Sell Up to 4 Million Paxlovid Doses to Poorer Nations
Boxes of Pfizer’s Paxlovid antiviral medication.
Photographer: Kobi Wolf/BloombergThis article is for subscribers only.
Pfizer Inc. will sell as many as 4 million doses of its Paxlovid pill for Covid-19 to low- and middle-income countries as part of an agreement with Unicef, the global relief organization.
Terms of the agreement to supply 95 countries with the drug were not released in the statement Tuesday from the New York-based drugmaker. Some upper-middle-income countries in Africa are also included in the deal, Pfizer said, and the company expects supply to be available in April and continue throughout the year.